← SynDRA
TAVAPADON
SynDRA canonical compound SYN0038406 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | DRD1 | DRD5 |
|---|
| Mechanism of action | dopamine agonist |
|---|
| Indication | parkinson's disease |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- DRD1 PARTIAL AGONIST
- Dopamine D1 receptor partial agonist
- DRD5 PARTIAL AGONIST
- Dopamine D5 receptor partial agonist
- dopamine agonist
Cross-references
Synonyms
- CVL-751
- PF-06649751
- Tavapadon [USAN]
- PT4P8MJP8L
- TAVAPADON [INN]
- UNII-PT4P8MJP8L
- Tavapadon (USAN)
- tavapadonum
- RefChem:187544
- (Rac)-Tavapadon
- Tavapadon?
- AKQXQLUNFKDZBN-UHFFFAOYSA-N
- Tavapadon (USAN/INN)
- orb1307698
- SCHEMBL16334991
- SCHEMBL29603955
- SCHEMBL30730655
- GTPL13372
- US10093655, Example 7
- US10093655, Example 8
- BDBM289097
- BDBM289098
- EX-A3416
- AKOS040742684
- HY-119486A
- AC-36997
- DA-67955
- MS-26523
- DB-186035
- CS-0131271
- D11431
- G17190
- H51057
- T16999
- PF-6649751
- タバパドン
Look up TAVAPADON in the interactive SynDRA portal →